M. Wagster

发表

Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Denise C. Park, A. Fagan, C. Jack, 2011, Alzheimer's & Dementia.

Frontal lobe volume in patients with Huntington's disease

G. Pearlson, E. Aylward, C. Ross, 1998, Neurology.

Assessment of neurological and behavioural function: the NIH Toolbox

N. Fox, R. Havlik, R. Gershon, 2010, The Lancet Neurology.

NIH Toolbox for Assessment of Neurological and Behavioral Function

N. Fox, C. Nowinski, R. Gershon, 2013, Neurology.

Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup

Denise C. Park, A. Fagan, C. Jack, 2011 .

Widespread expression of Huntington's disease gene (IT15) protein product

Christopher A Ross, David K Ryugo, Xiao-Jiang Li, 1995, Neuron.

Expression of the Huntington's disease (IT15) protein product in HD patients.

C. Ross, O. C. Stine, A. Sharp, 1995, Human molecular genetics.

News from the NIH: Person-centered outcomes measurement: NIH-supported measurement systems to evaluate self-assessed health, functional performance, and symptomatic toxicity

W. Riley, C. Moy, M. Wagster, 2016, Translational behavioral medicine.

The expectation breakers

J. King, M. Wagster, 2019, Neurobiology of Aging.

Nigral dopamine type-1 receptors are reduced in Huntington's disease: A postmortem autoradiographic study using [3H]SCH 23390 and correlation with [3H]forskolin binding

S. Folstein, D. Price, J. Hedreen, 1990, Experimental Neurology.

The 87%.

S. Resnick, J. King, P. Rapp, 2012, The journals of gerontology. Series A, Biological sciences and medical sciences.

Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease

D. Price, R. Mayeux, P. Whitehouse, 1988, Neurology.

The neural basis of memory decline in aged monkeys

D. Price, C. Kitt, M. Wagster, 1988, Neurobiology of Aging.

Bilateral changes in neocortical [3H]pirenzepine and [3H]oxotremorine-M binding following unilateral lesions of the rat nucleus basalis magnocellularis: an autoradiographic study

S. Rapoport, P. Whitehouse, G. Wenk, 1989, Brain Research.

Patients with features similar to Huntington's disease, without CAG expansion in huntingtin

J. Hodges, C. Ross, D. Rubinsztein, 1998, Neurology.

The NIH Cognitive and Emotional Health Project Report of the Critical Evaluation Study Committee

Lenore J. Launer, Marilyn S. Albert, David S. Knopman, 2006, Alzheimer's & Dementia.

DRPLA gene (atrophin-1) sequence and mRNA expression in human brain.

C. Ross, R. Margolis, W. Young, 1996, Brain research. Molecular brain research.

Huntington's disease gene (IT15) is widely expressed in human and rat tissues

S. Folstein, C. Ross, J. Hedreen, 1993, Neuron.

Depression and parkinson's disease: a new look at an old problem

W. McDonald, E. Edwards, C. Kitt, 2002, Depression and anxiety.

Aged Non‐Human Primates: An Animal Model of Age‐Associated Neurodegenerative Disease

D. Price, M. Wagster, V. Koliatsos, 1991, Brain pathology.

Assessment of cognition in early dementia

Joel H. Kramer, Ronald C. Petersen, Brian R. Ott, 2011, Alzheimer's & Dementia.

Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin.

C A Ross, C. Ross, T. Dawson, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Socialization processes in a female lowland gorilla

M. Wagster, Susan G. Brown, 1986 .

Brain health interventions: The need for further research

M. Wagster, M. Morrison‐Bogorad, V. Cahan, 2007, Alzheimer's & Dementia.

Developing Context and Background Underlying Cognitive Intervention/Training Studies in Older Populations.

M. Wagster, J. Elias, Molly V Wagster, 2007, The journals of gerontology. Series B, Psychological sciences and social sciences.

Dentatorubral and pallidoluysian atrophy (DRPLA) Clinical and neuropathological findings in genetically confirmed north american and european pedigrees

M. Porteous, M. Wagster, N. Ranen, 1997, Movement disorders : official journal of the Movement Disorder Society.

Selective Loss of [3H]Kainic Acid and [3H]AMPA Binding in Layer VI of Frontal Cortex in Huntington's Disease

S. Folstein, C. Ross, J. Hedreen, 1994, Experimental Neurology.

Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup

Denise C. Park, A. Fagan, C. Jack, 2011 .

Expression of the mutant allele of IT-15 (the HD gene) in striatum and cortex of Huntington's disease patients.

C. Ross, J. Hedreen, M. Wagster, 1995, Human molecular genetics.

Cognitive Aging Research: An Exciting Time for a Maturing Field

M. Wagster, 2009, Neuropsychology Review.

Changes in cholinergic receptor subtypes in behaviorally-tested, aged monkeys

M. Wagster, 1993, Neurobiology of Aging.